Mitva Patel, MD, on the Use of Contrast-Enhanced Mammograms

Video

The expert in breast imaging spoke about the use of the technology, and why it is more effective than traditional mammograms.

Contrast-enhanced mammograms are more sensitive than traditional mammograms, as they are able to provide detail that typically requires an MRI.

In addition, the technology is much faster and more cost-effective than traditional mammograms. Though contrast-enhanced mammograms are not yet widely available, the technology is steadily improving breast cancer detection.

In an interview with CancerNetwork®, Mitva Patel, MD, a radiologist at The Ohio State University Comprehensive Cancer Center (OSUCCC) who specializes in breast imaging, discussed the use of contrast-enhanced mammograms and how the technology may advance breast imaging moving forward.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences Medical World News, airing daily on all MJH Life Sciences channels.

Recent Videos
patient and provider
woman receiving mammogram
breast cancer screening
DNA
cancer
Related Content
Late-stage cancer and poor outcomes for patients may occur as a result of low screening numbers during the COVID-19 pandemic.

Reduction in Cancer Screenings During COVID-19 May Lead to More Late-Stage Disease, Poorer Outcomes

Hayley Virgil
November 29th 2021
Article

Late-stage cancer and poor outcomes for patients may occur as a result of low screening numbers during the COVID-19 pandemic.

Clinical Limit of Detection May Represent Viable cfDNA Metric For Detection of Multiple Cancers

Clinical Limit of Detection May Represent Viable cfDNA Metric For Detection of Multiple Cancers

Antonia DePace
September 19th 2021
Article

Data from the Circulating Cell-Free Genome Atlas on Clinical limit of detection, or cLOD, may help investigators better detect multiple cancers at earlier stages.

An integrated review highlights the barriers standing between diverse LGBTQ populations and cancer screenings.

Overcoming Barriers to Cancer Screening in Diverse LGBTQ Populations

Hayley Virgil
June 28th 2021
Article

An integrated review highlights the barriers standing between diverse LGBTQ populations and cancer screenings.

Decline in HPV-Related Cervical Cancer May Inform Screening and Vaccination Guidance for Other Tumor Types

Decline in HPV-Related Cervical Cancer May Inform Screening and Vaccination Guidance for Other Tumor Types

Audrey Sternberg
May 20th 2021
Article

Seventeen years of data indicate that HPV-related cervical cancer incidence is declining, but other tumors related to the virus persist.

USPSTF Lowers the Recommended Age for CRC Screenings, Mandating Insurance Coverage

USPSTF Lowers the Recommended Age for CRC Screenings, Mandating Insurance Coverage

Audrey Sternberg
May 18th 2021
Article

Recommendations published in JAMA are set to change colorectal cancer screening guidance for all individuals in the United States.

Next-Generation Sequencing for Advanced Pancreatic Cancer: A Technology Whose Time Has NOT Come

Next-Generation Sequencing for Advanced Pancreatic Cancer: A Technology Whose Time Has NOT Come

Howard S. Hochster, MD
May 15th 2021
Article

In his "Letter to the Readers", co-editor-in-chief of the journal ONCOLOGY Howard S. Hochster, MD, reviews the utility of next-generation sequencing in pancreatic ductal adenocarcinoma.